ProPhase Labs Inc [PRPH] stock is trading at $0.44, up 5.64%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The PRPH shares have gain 20.46% over the last week, with a monthly amount glided 15.12%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
ProPhase Labs Inc [NASDAQ: PRPH] stock has seen the most recent analyst activity on December 20, 2021, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $12. Previously, Dawson James downgraded its rating to Neutral on October 13, 2021. On January 20, 2021, Dawson James initiated with a Buy rating and assigned a price target of $25 on the stock.
ProPhase Labs Inc [PRPH] stock has fluctuated between $0.22 and $3.74 over the past year. Currently, Wall Street analysts expect the stock to reach $14 within the next 12 months. ProPhase Labs Inc [NASDAQ: PRPH] shares were valued at $0.44 at the most recent close of the market. An investor can expect a potential return of 3081.82% based on the average PRPH price forecast.
Analyzing the PRPH fundamentals
ProPhase Labs Inc [NASDAQ:PRPH] reported sales of 12.75M for the trailing twelve months, which represents a drop of -59.10%. Gross Profit Margin for this corporation currently stands at 0.18% with Operating Profit Margin at -7.44%, Pretax Profit Margin comes in at -8.36%, and Net Profit Margin reading is -9.44%. To continue investigating profitability, this company’s Return on Assets is posted at -0.86, Equity is -1.65 and Total Capital is -1.3. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.93.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4241 points at the first support level, and at 0.4060 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.4551, and for the 2nd resistance point, it is at 0.4680.
Ratios To Look Out For
For context, ProPhase Labs Inc’s Current Ratio is 1.03. In addition, the Quick Ratio stands at 0.98 and the Cash Ratio stands at 0.0. Considering the valuation of this stock, the price to sales ratio is 1.44, the price to book ratio is 1.18.
